Clustering data with hclust algorithm for Effects of the Kinase Inhibitor Sorafenib on Serum Metabolism In Vivo using Non-targeted Metabolomics Analysis tissue). (Study ST000574)

GC POSITIVE ION MODE (Analysis AN000884)
MetaboliteStructureF1F2
C16 HydrocarbonME1695140.971.04
Stearic acidME1695650.971.03
Malic acidME1695440.971.03
5^-Deoxy-5^-(methylthio) adenosineME1694930.971.03
DisaccharideME1695240.971.03
alpha-MonostearinME1695010.961.05
AdenineME1694960.961.04
SqualeneME1695640.961.04
alpha Ketoglutaric acidME1694991.020.98
Uric acidME1695741.010.99
O-PhosphocolamineME1695531.010.99
Malonic acidME1695451.010.99
GlutamineME1695311.010.99
CreatinineME1695211.010.99
C14 HydrocarbonME1695121.010.99
C13 hydrocarbonME1695111.010.99
Benzoic acidME1695071.010.99
Aspartic acidME1695061.010.99
3-Aminoisobutyric acid/beta-AlanineME1694911.010.99
AlanineME1694971.010.99
Fructose or similar ketohexoseME1695270.981.03
Tetradecanedioic acidME1695680.981.02
SpermidineME1695630.981.02
SiloxanesME1695620.981.02
Palmitic acidME1695540.981.02
N-Methylalanine/2-Aminobutanoic acid/N-EthylglycineME1695500.981.02
Myoinositol-2-phosphateME1695480.981.02
Methionine sulfoxideME1695460.981.02
Inosine/AdenosineME1695390.981.02
alpha-MonopalmitinME1695000.981.02
deuterated Myristic Acid (RTL std)ME1695220.981.02
Aminomalonic acidME1695030.991.02
Tryptamine/NorepinephrineME1695720.991.02
UracilME1695731.001.00
Tiglic acidME1695701.001.00
Threonic acid/erythronic acidME1695691.001.00
Sucrose and similar disaccharidesME1695661.001.00
Pyruvic acidME1695611.001.00
Phosphoenolpyruvic acidME1695581.001.00
Pantothenic acidME1695551.001.00
O-MethylphosphateME1695521.001.00
Nonanoic acidME1695511.001.00
MyoinositolME1695471.001.00
LysineME1695431.001.00
Lauric acidME1695411.001.00
Isoleucine/LeucineME1695401.001.00
HexitolsME1695361.001.00
Hexanoic acid (and/or Glycolic acid)ME1695351.001.00
GlycineME1695331.001.00
GlycerolME1695321.001.00
Glucose and other aldohexosesME1695301.001.00
Fumaric acidME1695281.001.00
EthanolamineME1695261.001.00
CampesterolME1695181.001.00
C20 HydrocarbonME1695171.001.00
C19 hydrocarbonME1695161.001.00
C15 hydrocarbonME1695131.001.00
beta-SitosterolME1695101.001.00
beta-MonostearinME1695091.001.00
Acetoacetate/2-Aminoisobutanoic acidME1694951.001.00
Ascorbic acid/Isoascorbic acidME1695051.001.00
C18 HydrocarbonME1695150.981.01
AldopentosesME1694981.001.01
UridineME1695750.991.01
TrisaccharideME1695710.991.01
TaurineME1695670.991.01
PseudouridineME1695600.991.01
ProlineME1695590.991.01
PhenylalanineME1695570.991.01
PentitolsME1695560.991.01
Myristic acid or PentadecanolME1695490.991.01
Linoleic acidME1695420.991.01
HypoxanthineME1695380.991.01
HydroxyprolinesME1695370.991.01
Heptadecanoic acid/OctadecanolME1695340.991.01
gamma-Hydroxybutyric acidME1695290.991.01
Erythritol/TheitolME1695250.991.01
Dihydroxyacetone phosphateME1695230.991.01
CarnosineME1695200.991.01
CarnitineME1695190.991.01
beta-MonopalmitinME1695080.991.01
Arachidonic acid (also Eicosapentaenoic acid)ME1695040.991.01
alpha-TocopherolME1695020.991.01
6-Hydroxynicotinic acidME1694940.991.01
2-HydroxypyridineME1694900.991.01
3-Phosphoglyceric acidME1694920.991.01

Factors:

F1Vehicle (PBS) Control Treatment:30 mg/kg Sorafenib Treatment
F2Vehicle (PBS) Control Treatment:Vehicle (PBS) Control Treatment
Data matrix
  logo